Trials / Unknown
UnknownNCT03567044
Immune Effects in Patients Treated With Whole Breast Irradiation
Outcomes and Immune Effects in Patients With Early Stage Breast Cancer Treated With Lumpectomy and Whole Breast Irradiation.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University of Virginia · Academic / Other
- Sex
- Female
- Age
- 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to obtain data to determine whether whole breast irradiation (WBI) differentially influences the frequency of components of innate and adaptive immunity and their relative functional activity, to assess the patient's quality of life (QOL) and to evaluate the cosmetic assessment of the breast on follow-up after WBI treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood Draw | Eligible subjects will have blood draws at the following times: baseline, 1 week, 4 weeks, 8 weeks, 12 weeks, 24 weeks. |
Timeline
- Start date
- 2018-10-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2018-06-25
- Last updated
- 2018-06-25
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03567044. Inclusion in this directory is not an endorsement.